Lilly Ventures Fund I LLC → Protagonist Therapeutics, Inc PTGX

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-03-31

DTC 7.64

8,626,880 shares short · +7.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

2 holders · $8.75M

Duquesne Family OfficeSoros Fund Management

Other 13D/G Filings on Protagonist Therapeutics, Inc

Filed	Form	Filer	Stake	Shares
2018-01-04	SC	ADAGE CAPITAL PARTNERS GP, L.L.C.	—	—	view →

Other Filings by Lilly Ventures Fund I LLC

Filed	Form	Issuer	Stake	Shares
2019-08-13	SC	AILERON THERAPEUTICS INC RNTX	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →